Dyslipidemia Management in Chinese Post Stroke Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01897883

Enrollment

5000

Registered

2013-07-12

Start date

2013-07-31

Completion date

2014-08-31

Last updated

2015-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Ischemia,Stoke

Brief summary

The purpose of this study is to provide current and reliable data of dyslipidimia management together with control situation of blood pressure and glucose for post-stroke patients within 6-12 months from attack, and also the association between patient characteristics and control rate of lipids in this population. It is an non-interventional study, no study specified treatment is required.Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.

Detailed description

This is a multicentre, cross-sectional, observational study, aiming to investigate the prevalence and control situation of dyslipidimia in China post ischemic stroke patients within 6-12 months from attack. Patients will be screened consecutively, eligible subjects will be interviewed by investigator and finish a questionire during the visit. Investigator will collect relevant medical history, physical exam results and lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) and glucose(HbA1c if available).Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Male or female with age ≥ 18 years 2. Post ischemic stroke patients within 6-12 months from attack 3. written informed consent is provided to participant in the study

Exclusion criteria

1. Significant medical or psychological condition that make patients can not finish the questionnaire independently or with the aids of his/her legal representatives 2. The patient is or will be in another clinical study 3. Previous enrolment in the present study

Design outcomes

Primary

Measure	Time frame	Description
To observe LDL-C level of China post-stroke patients within 6-12 months from attack	Up to 12 months	Investigator will collect lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) during the patient visit.
To observe control rate of LDL-C of China post-stroke patients within 6-12 months from attack	Up to 12 months	—

Countries

China

Outcome results